David G. Alberg

1.3k total citations
18 papers, 1.1k citations indexed

About

David G. Alberg is a scholar working on Molecular Biology, Organic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David G. Alberg has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David G. Alberg's work include Signaling Pathways in Disease (7 papers), Research on Leishmaniasis Studies (4 papers) and Fungal Plant Pathogen Control (3 papers). David G. Alberg is often cited by papers focused on Signaling Pathways in Disease (7 papers), Research on Leishmaniasis Studies (4 papers) and Fungal Plant Pathogen Control (3 papers). David G. Alberg collaborates with scholars based in United States and Denmark. David G. Alberg's co-authors include Stuart L. Schreiber, Peter J. Belshaw, Sheng Luan, Mark W. Albers, Carol MacKintosh, Claude B. Klee, Thomas J. Wandless, Philip Cohen, Paul A. Bartlett and Ramsay Fuleihan and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Clinical Investigation.

In The Last Decade

David G. Alberg

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David G. Alberg United States 13 760 262 191 182 73 18 1.1k
Silvia Franchini Italy 17 546 0.7× 421 1.6× 166 0.9× 103 0.6× 196 2.7× 56 1.2k
Sam L. Koprak United States 10 1.1k 1.5× 455 1.7× 162 0.8× 368 2.0× 82 1.1× 10 1.5k
David Conrad Canada 16 415 0.5× 305 1.2× 41 0.2× 189 1.0× 45 0.6× 44 981
Carol Homon United States 12 836 1.1× 176 0.7× 95 0.5× 148 0.8× 31 0.4× 21 1.2k
Jianhe Peng United Kingdom 16 784 1.0× 59 0.2× 156 0.8× 75 0.4× 34 0.5× 32 1.2k
M. Kuwabara Japan 17 440 0.6× 151 0.6× 51 0.3× 72 0.4× 49 0.7× 43 896
G. Harris United Kingdom 19 463 0.6× 388 1.5× 49 0.3× 79 0.4× 17 0.2× 50 1.1k
Thomas D. Sweitzer United States 12 630 0.8× 83 0.3× 65 0.3× 61 0.3× 23 0.3× 15 910
Lowell M. Greenbaum United States 24 641 0.8× 245 0.9× 87 0.5× 201 1.1× 156 2.1× 67 1.6k

Countries citing papers authored by David G. Alberg

Since Specialization
Citations

This map shows the geographic impact of David G. Alberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Alberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Alberg more than expected).

Fields of papers citing papers by David G. Alberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Alberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Alberg. The network helps show where David G. Alberg may publish in the future.

Co-authorship network of co-authors of David G. Alberg

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Alberg. A scholar is included among the top collaborators of David G. Alberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Alberg. David G. Alberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mohrig, Jerry R., et al.. (2014). Laboratory techniques in organic chemistry : supporting inquiry-driven experiments. 3 indexed citations
2.
Duyzend, Michael, Aaron M. Leconte, Andrew W. Wills, et al.. (2011). Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase. Journal of Enzyme Inhibition and Medicinal Chemistry. 27(6). 784–794. 11 indexed citations
3.
Hofmeister, Gretchen E., et al.. (2010). Transition‐Metal‐Free Formal Sonogashira Coupling and α‐Carbonyl Arylation Reactions. Chemistry - A European Journal. 16(12). 3783–3790. 40 indexed citations
4.
Alberg, David G., et al.. (2009). Organocatalysis with endogenous compounds: Towards novel non-enzymatic reactions. Bioorganic & Medicinal Chemistry Letters. 19(14). 3888–3891. 10 indexed citations
5.
Mohrig, Jerry R., et al.. (2008). Stereochemistry of 1,2-elimination reactions at the E2–E1cB interface—tert-butyl 3-tosyloxybutanoate and its thioester. Organic & Biomolecular Chemistry. 6(9). 1641–1641. 11 indexed citations
6.
Czechowicz, Josephine A., et al.. (2007). The Synthesis and Inhibitory Activity of Dethiotrypanothione and Analogues against Trypanothione Reductase. The Journal of Organic Chemistry. 72(10). 3689–3693. 13 indexed citations
7.
Funke, T., M.L. Healy-Fried, Huijong Han, et al.. (2007). Differential Inhibition of Class I and Class II 5-Enolpyruvylshikimate-3-phosphate Synthases by Tetrahedral Reaction Intermediate Analogues,. Biochemistry. 46(46). 13344–13351. 25 indexed citations
8.
Priestman, Melanie A., Andreas Becker, David G. Alberg, et al.. (2005). Interaction of Phosphonate Analogues of the Tetrahedral Reaction Intermediate with 5-Enolpyruvylshikimate-3-phosphate Synthase in Atomic Detail,. Biochemistry. 44(9). 3241–3248. 28 indexed citations
9.
Cook, Brian N., et al.. (2000). Inhibition of Trypanothione Reductase by Substrate Analogues. Organic Letters. 2(23). 3639–3642. 25 indexed citations
10.
Belshaw, Peter J., Stephanie Meyer, Donna Johnson, et al.. (1994). Synthesis, Structure and Mechanism in Immunophilin Research. Synlett. 1994(6). 381–392. 24 indexed citations
11.
Ke, Hengming, Peter J. Belshaw, David G. Alberg, et al.. (1994). Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A. Structure. 2(1). 33–44. 60 indexed citations
12.
Fuleihan, Ramsay, N Ramesh, A Horner, et al.. (1994). Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.. Journal of Clinical Investigation. 93(3). 1315–1320. 121 indexed citations
13.
Lyson, T, et al.. (1993). Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling.. Circulation Research. 73(3). 596–602. 78 indexed citations
14.
Alberg, David G. & Stuart L. Schreiber. (1993). Structure-Based Design of a Cyclophilin-Calcineurin Bridging Ligand. Science. 262(5131). 248–250. 56 indexed citations
15.
Albers, Mark W., Thomas J. Wandless, Sheng Luan, et al.. (1992). Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry. 31(16). 3896–3901. 484 indexed citations
16.
Rosen, Michael K., Peter J. Belshaw, David G. Alberg, & Stuart L. Schreiber. (1992). The conformation of cyclosporin a bound to cyclophilin is altered (once again) following binding to calcineurin: an analysis of receptor-ligand-receptor interactions. Bioorganic & Medicinal Chemistry Letters. 2(7). 747–753. 7 indexed citations
17.
Alberg, David G., et al.. (1992). Inhibition of 5-enolpyruvoylshikimate 3-phosphate (EPSP) synthase by analogs of the tetrahedral intermediate and of EPSP. Journal of the American Chemical Society. 114(9). 3535–3546. 52 indexed citations
18.
Alberg, David G. & Paul A. Bartlett. (1989). Potent inhibition of 5-enolpyruvylshikimate-3-phosphate synthase by a reaction intermediate analog. Journal of the American Chemical Society. 111(6). 2337–2338. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026